ESCMID - European Society of Clinical Microbiology and Infectious Diseases

Our brand has changed, our ambitions stay the same! ESCMID modernises its visual identity. As we strive for pioneering research and state-of-the-art education, we also want to communicate in a way that is effective in our time and fit for the next decade.

📚 Join our experienced lecturers to learn about a wide variety of hot topics, including: • Methodological issues around predictive #AI • Large national #databases • Adaptive designs for randomised #clinicaltrials  • Time-to-event analyses in clinical #epidemiology  • Systematic reviews and meta-analyses ... and more! Read about the course 👉🏻 https://lnkd.in/esWshVsU 🧑🏽⚕️👨🏻🔬 Among the experts returning this year are Aleksandra Barac 🇷🇸, Henri van Werkhoven 🇳🇱, Jesús Rodríguez-Baño 🇪🇸, Leonard Leibovici 🇮🇱, Luigia Scudeller 🇮🇹, Marc Bonten 🇳🇱, Marcela Krůtová 🇨🇿, Mariska Leeflang 🇳🇱, Martin Wolkewitz 🇩🇪, Mette Nørgaard 🇩🇰, Mical Paul 🇮🇱, Pontus Naucler 🇸🇪, and Tanya Babich 🇩🇪. Organised by Ecraid and ESCMID - European Society of Clinical Microbiology and Infectious Diseases University of Belgrade, Charles University, Albert-Ludwigs-Universität Freiburg im Breisgau, Tel Aviv University, Amsterdam UMC, Aarhus University, IRCCS Policlinico di Sant’Orsola - Azienda Ospedaliero Universitaria di Bologna , UMC Utrecht

Don't miss the upcoming GARDP webinar on 23 July: ‘The value of surveillance data in defining the medical need for new antimicrobials’ showcasing the value of susceptibility surveillance data in defining the need for new antibacterials, designing target product profiles and planning clinical trials. Register here: https://ow.ly/akYl50StE6b

★ Just published a new #Communicable podcast episode -- Beauty is in the 'I' of the beholder: recent #EUCAST updates https://lnkd.in/d8CdwHDh #clinicalbreakpoints #susceptibledosedependent #SDDlabel #epidemiologicalcutoffvalue #ECOFF #antimicrobialsusceptibilitytesting #AST #fosfomycin #clinicalmicrobiology #antimicrobialstewardship #ESCMID #CMIComms #OpenAccess

Wrap up with day 4 on the YouTube series where renowned German illustrator Frank Flöthmann drew amazing graphical abstracts for some of our most interesting #ESCMIDGlobal2024 sessions and Keynote lectures. 📺📺 https://ow.ly/WN5T50RTLU8 📺📺

For our new series on #ESCMIDGlobal25, check out programme committee members Anu Kantele and Carlos Seas highlighting parasitology, travel medicine and one health as part of the of the invited programme. 📺📺 https://ow.ly/1RWh50SxBVI 📺📺

Check out another issue of "The Story Behind the Study" from #CMI! Beyond the lab environments and complex data, there lies a captivating story waiting to be unveiled - a story that speaks of challenges, cooperation, and the pursuit of understanding infection, in order to help patients. https://ow.ly/kx0N50SywmM

Two ESCMID Courses are available for registration covering "Ethics in CM and ID" and "Maths against AMR" which are taking place in October. Learn more and secure your spot in this and our other upcoming courses on our website: https://lnkd.in/dK9zwnJ5 #AMR #Ethics #ESCMIDEdu

Don’t blame the bugs! #WGS analysis of 66 #groupAStrep strains from before, during & after #COVID19 shows no evidence that invasive disease increase is due to more virulent #iGAS strains. Rather we humans as hosts have likely changed in our susceptibility since COVID19. https://ow.ly/QyJs50Sx2Ej #GroupAStreptococcus #GAS #iGAS #StrepA #GroupAStrep #streptococcal #infection #wholegenomesequencing #WGS #infectiousdisease #ID #PublicHealth #CMIComms #OpenAccess #ESCMID

Only 1 week left to apply to join the ESCMID Ethics Advisory Committee. We are searching for new members for this independent body which counsels on specific ethical, regulatory, social and philosophical issues related to ESCMID. Apply before July 15: https://ow.ly/XmFv50SvbBR